GOLM1
Basic information
Region (hg38): 9:86026146-86100173
Previous symbols: [ "GOLPH2", "C9orf155" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GOLM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 21 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 3 | 3 |
Variants in GOLM1
This is a list of pathogenic ClinVar variants found in the GOLM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-86027833-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
9-86027852-G-A | not specified | Uncertain significance (Sep 13, 2023) | ||
9-86027879-C-A | not specified | Uncertain significance (Mar 25, 2024) | ||
9-86033287-A-G | not specified | Uncertain significance (Aug 27, 2024) | ||
9-86033359-T-C | not specified | Uncertain significance (Oct 26, 2022) | ||
9-86033395-C-T | not specified | Uncertain significance (Feb 04, 2022) | ||
9-86035392-C-T | not specified | Uncertain significance (Oct 30, 2023) | ||
9-86035405-G-A | Benign (Mar 29, 2018) | |||
9-86035513-G-A | Benign (Jun 27, 2018) | |||
9-86035513-G-C | not specified | Uncertain significance (Mar 20, 2023) | ||
9-86035556-C-T | not specified | Likely benign (Jul 08, 2022) | ||
9-86035558-G-A | Likely benign (Dec 01, 2022) | |||
9-86035580-T-A | not specified | Uncertain significance (Nov 11, 2024) | ||
9-86035592-T-G | not specified | Uncertain significance (Jun 26, 2024) | ||
9-86036354-C-G | not specified | Uncertain significance (May 31, 2023) | ||
9-86036423-G-A | not specified | Uncertain significance (Oct 25, 2024) | ||
9-86036426-C-T | not specified | Uncertain significance (Nov 15, 2021) | ||
9-86036434-T-A | not specified | Uncertain significance (Sep 23, 2023) | ||
9-86036450-C-G | not specified | Uncertain significance (Jan 26, 2022) | ||
9-86040753-C-T | not specified | Uncertain significance (Jun 04, 2024) | ||
9-86040755-T-C | not specified | Uncertain significance (Apr 19, 2023) | ||
9-86040756-T-C | not specified | Uncertain significance (Mar 17, 2023) | ||
9-86046467-C-T | Benign (Dec 31, 2019) | |||
9-86046512-T-A | not specified | Uncertain significance (Nov 03, 2023) | ||
9-86046538-C-G | Benign (Jan 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GOLM1 | protein_coding | protein_coding | ENST00000388712 | 9 | 74028 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.62e-9 | 0.754 | 125710 | 0 | 37 | 125747 | 0.000147 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.758 | 200 | 233 | 0.860 | 0.0000137 | 2629 |
Missense in Polyphen | 47 | 53.046 | 0.88602 | 530 | ||
Synonymous | -0.191 | 96 | 93.7 | 1.03 | 0.00000586 | 746 |
Loss of Function | 1.43 | 16 | 23.5 | 0.681 | 0.00000126 | 244 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000211 | 0.000211 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.000232 | 0.000231 |
European (Non-Finnish) | 0.000142 | 0.000141 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Unknown. Cellular response protein to viral infection.;
- Pathway
- Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
(Consensus)
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.764
- rvis_EVS
- 0.64
- rvis_percentile_EVS
- 84.05
Haploinsufficiency Scores
- pHI
- 0.396
- hipred
- N
- hipred_score
- 0.198
- ghis
- 0.471
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.909
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Golm1
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- nucleus organization;regulation of lipid metabolic process;post-translational protein modification;cellular protein metabolic process
- Cellular component
- extracellular space;endoplasmic reticulum lumen;Golgi apparatus;integral component of plasma membrane
- Molecular function
- protein binding